Aducanumab (Pending FDA Approval)

Classes: Monoclonal Antibodies, Anti-amyloid Beta

What is Aducanumab?

Aducanumab is under study as a possible treatment of early Alzheimer’s disease and currently pending FDA approval.

Uses of Aducanumab

• possible treatment of early Alzheimer’s disease.

Side effects

Consult your doctor immediately if any side effects occur, worsen, persist or any serious side effects occur.

Precautions

Consult your Physician.